1) Biological Warfare Defense Therapeutics
Abstract
Funds biomedical research focused on the nonclinical and early clinical development of therapeutic countermeasures against known and emerging viral, bacterial, and toxin biological warfare (BW) threats for which U.S. Food & Drug Administration (FDA) approved therapeutics are limited or lacking.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2025
- Source ID
- b2f25dc698f86b42815ad3290a04f386